Select A Country

International Office Sites

- English
- English /
- 简体中文
- English /
- 한국

Join Our Mailing List /
Careers /
Contact

All
Biographies
Practices
Industries
Newsroom

Firm
Biographies
Browse by last name:
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- Biographies
Advanced Search
Practices
View All Practices

Analytics & Behavioral Science Consulting (R&G Insights Lab)

Anti-Corruption / International Risk

Antitrust

Appellate & Supreme Court

Asset Management

Asset Management ESG

Asset Management M&A

Banking

Benefits Consulting Group

Business & Commercial Litigation

Business Restructuring

California Consumer Privacy Act

Capital Markets

Charitable Foundations

Consumer Protection and Advertising Law

Corporate & Securities Litigation

Corporate Governance & Compliance
COVID-19

Credit Funds

Cryptocurrency

Data, Privacy & Cybersecurity

Derivatives & Commodities

Digital Health

Drug Pricing & Price Reporting

E-Discovery

Educational Institutions

Employment

ERISA

ESG, CSR and Business and Human Rights

Executive Compensation & Employee Benefits

False Claims Act

Family Offices

FDA Regulatory

Finance

FinTech
General Data Protection Regulation

Global Fraud Task Force

Global Reach

Government Enforcement / White Collar Criminal Defense

Health Care

Hedge Funds

IBOR Transition

Independent Investigations

Intellectual Property

Investment Management

Liability Risk Management

Life Sciences

Litigation

Mergers & Acquisitions

Natural Resources

Private Client

Private Equity

Private Funds
Real Estate Investments & Transactions

Registered Funds

Risk Management

Securities & Futures Enforcement

Securities & Public Companies

Sexual Misconduct & Workplace Harassment

Shareholder Engagement and Activism

Social Media

Special Purpose Acquisition Companies

Special Situations

Sports

Tax

Tax Controversy

Tax-Exempt Organizations

Technology, Media & Telecommunications

Venture Capital & Emerging Companies
Industries
View All Industries

Automotive & Transportation

Educational Institutions

Energy & Infrastructure

Financial Institutions
Health Care

Hedge Funds

Internet, e-Commerce & Social Media

Investment Management

Life Sciences
Manufacturing & Industrial Services

Mechanical Engineering

Private Equity

Real Estate

Retail & Consumer Brands
Sovereign Wealth Funds

Sports

Technology, Media & Telecommunications
Locations
Offices
- Boston
- Chicago
- Hong Kong
- London
- New York
- San Francisco
- Seoul
- Shanghai
- Silicon Valley
- Tokyo
- Washington, DC
Global Reach
- Africa
- Americas
- Asia Pacific
- Brazil
- Europe
- India
- Israel
- Latin America
- Middle East
Newsroom
Careers
Contact
Select A Country
International Office Sites
- - English
- - English /
  - 简体中文
- - English /
  - 한국

Home»
Newsroom»
Alerts»
China SFDA Creates New Regulatory Pathways for Transfer...

Alert

News
Alerts
Rankings & Awards
Podcasts
Resource Centers & Blogs
Videos
Events & Webinars

China SFDA Creates New Regulatory Pathways for Transfer of Drug Licenses

March 4, 2013 Practices: Life Sciences, China Life Sciences

Printer-Friendly Version

Industries

Biotechnology & Pharmaceuticals

Focus on:

Capital Insights /
CSR and Supply Chain Compliance /
China Life Sciences Insights /
Global Health Care Compliance /
Physician-Owned Distributors /
Value-Based Health Care Initiative

Advertising /
Legal Notices /
Privacy /
Site Map

Copyright © 2021 Ropes & Gray LLP. All rights reserved. Attorney advertising. Prior results do not guarantee a similar outcome.

Cookie Settings